Management of suspected multiple myeloma?
Hello, my father is 64 years old.
Recently, a blood test revealed a hemoglobin level of 9.4 gm/dL.
Despite multiple blood transfusions, his hemoglobin remains below 10 gm/dL, prompting further examination.
The results showed the following: Na=132 mmol/L, IgG=3292 gm/dL, HbA1c=6.9%, Immunoelectrophoresis-Albumin=43.4%, Alpha-2=5.8%, Beta=11%, Gamma=37.7%.
The doctor indicated that there is a confirmed issue with the bone marrow, with a 20% possibility of bone marrow cancer.
Follow-up blood tests are scheduled for the next three months, and he should return for a check-up if he experiences any bone pain.
Currently, my father does not have any bone pain, but he recently had a kidney inflammation (the index is decreasing).
After researching online, I still have many concerns.
I would like to ask Dr.
Chen: 1.
Based on the current values, should we seek other aggressive treatments? 2.
Are there any precautions he should take in daily life, such as dietary or lifestyle changes? 3.
Could you recommend a specialist in the northern region (preferably in Taipei)? Thank you.
Ellen, 30~39 year old female. Ask Date: 2021/02/18
Dr. Chen Yunfang reply Oncology
Hello: 1.
Have you confirmed a diagnosis of multiple myeloma? So you received a major illness certificate? Based on your statement, it is impossible because a bone marrow aspiration has not been performed! Without a bone marrow aspiration, a diagnosis of myeloma cannot be made.
A blood test can only raise suspicion; it cannot be used as a basis for diagnosis.
Therefore, points 1 and 2 are not worth discussing.
2.
You can see any hematologist in the outpatient clinic.
Thank you.
Reply Date: 2021/02/18
More Info
Managing suspected multiple myeloma (MM) is a complex process that requires careful evaluation and monitoring. Given your father's recent lab results and the concerns regarding his health, here are some key insights and recommendations.
1. Evaluation of Current Lab Results
Your father's hemoglobin level of 9.4 g/dL indicates anemia, which is common in multiple myeloma due to bone marrow infiltration by malignant plasma cells. The elevated IgG level (3292 g/dL) suggests a significant monoclonal protein presence, which is a hallmark of multiple myeloma. The sodium level of 132 mmol/L indicates hyponatremia, which can occur in various conditions, including renal issues or fluid overload, and should be monitored closely.
The fact that the doctor has indicated a 20% chance of bone marrow cancer suggests that further diagnostic workup is warranted. While the current recommendation is to monitor with follow-up blood tests in three months, it is essential to consider additional tests such as a bone marrow biopsy, imaging studies (like MRI or CT scans), and possibly a referral to a hematologist specializing in multiple myeloma for a more comprehensive evaluation.
2. Need for Active Treatment
Whether your father requires immediate treatment depends on several factors, including the presence of symptoms, the extent of bone marrow involvement, and the results of any additional tests. If he develops symptoms such as bone pain, renal impairment, or hypercalcemia, treatment may need to be initiated sooner. Common treatment options for multiple myeloma include:
- Chemotherapy: Often used in combination with other agents.
- Targeted Therapy: Such as proteasome inhibitors (e.g., bortezomib) or immunomodulatory drugs (e.g., lenalidomide).
- Stem Cell Transplantation: Considered for eligible patients, particularly younger individuals or those with fewer comorbidities.
3. Lifestyle and Dietary Considerations
While your father is currently asymptomatic, there are several lifestyle modifications that can help manage his health:
- Hydration: Ensuring adequate fluid intake is crucial, especially if there are concerns about renal function.
- Diet: A balanced diet rich in fruits, vegetables, lean proteins, and whole grains can support overall health. Limiting salt intake may help manage blood pressure and fluid balance.
- Regular Monitoring: Keeping regular appointments with his healthcare provider for blood tests and monitoring of symptoms is essential.
- Physical Activity: Encourage gentle exercise as tolerated, which can help maintain strength and mobility.
4. Seeking Specialist Care
For specialized care in multiple myeloma, it is advisable to consult a hematologist or an oncologist with experience in treating blood cancers. In Taipei, several reputable hospitals and clinics have hematology departments specializing in multiple myeloma. Some notable institutions include:
- National Taiwan University Hospital: Known for its comprehensive cancer care and research.
- Taipei Veterans General Hospital: Offers specialized services in hematology and oncology.
- Chang Gung Memorial Hospital: Renowned for its cancer treatment programs.
Conclusion
In summary, while your father's current lab results indicate a potential issue with multiple myeloma, the decision for active treatment should be based on further evaluation and clinical symptoms. Regular follow-up and monitoring are crucial, along with lifestyle modifications to support his health. Consulting with a specialist will provide a clearer path forward and help address any concerns you may have. Always ensure that any treatment decisions are made in collaboration with his healthcare team.
Similar Q&A
Understanding Multiple Myeloma: Risks and Treatment Options Explained
What is multiple myeloma? What are its dangers? What treatment options are available? <Stage III> Thank you!
Dr. Yang Youhua reply Oncology
Multiple myeloma is a malignancy characterized by the uncontrolled proliferation of plasma cells in the bone marrow, leading to the excessive production of monoclonal immunoglobulin. Cancer cells secrete cytokines that stimulate osteoclasts, resulting in bone pain, multiple fract...[Read More] Understanding Multiple Myeloma: Risks and Treatment Options Explained
Understanding High-Risk Groups for Multiple Myeloma: Prevention and Management
Hello Director Lai, Last year, my father was informed that he is in a high-risk group for multiple myeloma, which was discovered through blood test results. The doctor advised that he should have blood tests every three months to check for any abnormal indices. My question is, b...
Dr. Lai Yicheng reply Oncology
Mr. Shen: In response to your inquiry regarding your father's high-risk status for multiple myeloma, I would like to provide the following information: 1. It is generally recognized that risk factors for multiple myeloma include: age, gender (male > female), race (Black...[Read More] Understanding High-Risk Groups for Multiple Myeloma: Prevention and Management
Understanding Multiple Myeloma: Concerns on Cancer Markers and Treatment Options
Hello Doctor: My mother previously underwent a bone marrow biopsy, which revealed multiple myeloma with cancer markers exceeding 10,000. I have a few questions: 1. Are cancer markers standardized, and is this level considered very serious? (It seems to be related to immunoglobuli...
Dr. Fan Sheng reply Oncology
Dear Mr. Hsieh: 1. Different types of cancer have their specific tumor markers. Immunoglobulins can be used to assess the condition of multiple myeloma, and values in the tens of thousands indicate a severe situation. 2. Combining Venclexta with other medications in the first...[Read More] Understanding Multiple Myeloma: Concerns on Cancer Markers and Treatment Options
Understanding Monoclonal Gammopathy: Risks and Management Strategies
My mother was informed during a blood test at Taipei Veterans General Hospital that her IgG levels were elevated (first test 1685, second test 1698) and her Kappa/Lambda ratio (approximately 20 in the first test, about 22 in the second test). The doctor, concerned about the first...
Dr. Hu Ziren reply Oncology
This condition cannot be prevented; subsequent follow-up is more important. If concerned, it is advisable to return for a check-up every six months. If any of the following situations occur, it is recommended to schedule an earlier appointment: worsening kidney function (decrease...[Read More] Understanding Monoclonal Gammopathy: Risks and Management Strategies
Related FAQ
(Oncology)
Lymphoma(Oncology)
Thalassemia(Oncology)
Cancer Treatment(Oncology)
Melanoma(Oncology)
Blood(Oncology)
Aplastic Anemia(Oncology)
Cancer Screening(Oncology)
Thrombocytosis(Oncology)
Pheochromocytoma(Oncology)